Bendamustine is a nitrogen mustard drug indicated for use in the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. Bendamustine is a bifunctional mechlorethamine derivative capable of forming electrophili...
Bendamustine is indicated for use in the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Seby B. Jones Cancer Center, Boone, North Carolina, United States
Northeast Medical Center, Concord, North Carolina, United States
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
Maine Center for Cancer Medicine, Scarborough, Maine, United States
Duke University Medical Center, Durham, North Carolina, United States
Tufts Medical Center, Boston, Massachusetts, United States
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
Columbia University, New York, New York, United States
For additional information regarding sites for this trial call (919) 465-4648, Navarre, Spain
IU Health Central Indiana Cancer Centers, Indianapolis, Indiana, United States
Metro Health Cancer Care, Wyoming, Michigan, United States
Community Regional Cancer Center, Indianapolis, Indiana, United States
Dept. of Hematology and Oncology, Charité, Campus Virchow Klinikum Charité, Berlin, Germany
Dept. of Hematology and Oncology, Charité, Campus Benjamin Franklin, Berlin, Germany
Dept. of Hematology and Oncology, Charité, Campus Charité Mitte, Berlin, Germany
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
UT MD Anderson Cancer Center, Houston, Texas, United States
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.